Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
API
0
FDF
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 2-((1-ethoxycarbony)-3-phenylpropylamino-1-oxopropyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic Acid
2. Fempress
3. Moex
4. Moexipril
5. Perdix
6. Rs 10085
7. Rs-10085
8. Univasc
1. Moexipril Hcl
2. 82586-52-5
3. Univasc
4. Spm 925
5. Ci 925
6. Moexipril Hydrochloride [usan]
7. Moexipril (hydrochloride)
8. Spm-925
9. Ci-925
10. Rs-10085-197
11. Q1umg3uh45
12. Rs-10085
13. Dsstox_cid_24267
14. Dsstox_rid_80137
15. Dsstox_gsid_44267
16. (3s)-2-((2s)-n-((1s)-1-carboxy-3-phenylpropyl)alanyl)-1,2,3,4-tetrahydro-6,7-dimethoxy-3-isoquinolinecarboxylic Acid, 2-ethyl Ester, Monohydrochloride
17. (3s)-2-[(2s)-2-[[(1s)-1-ethoxycarbonyl-3-phenyl-propyl]amino]propanoyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinoline-3-carboxylic Acid Hydrochloride
18. (3s)-2-[(2s)-2-[[(2s)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinoline-3-carboxylic Acid;hydrochloride
19. 3-isoquinolinecarboxylic Acid, 2-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)-1,2,3,4-tetrahydro-6,7-dimethoxy-, Monohydrochloride, (3s-(2(r*(r*)),3r*))-
20. Unii-q1umg3uh45
21. Cas-82586-52-5
22. Femipres
23. Primoxil
24. Rs 10085-197
25. (3s)-2-[(2s)-2-[[(1s)-1-(ethoxycarbonyl)-3-phenyl-d5-propyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-3-isoquinolinecarboxylic Acid Hydrochloride
26. Univasc (tn)
27. Moexipril Hcl- Bio-x
28. Ncgc00167834-01
29. Rs 10085
30. 5-hydroxy-2-iodobenzoicacid
31. Schembl40877
32. Mls003882580
33. Moexipril Hydrochloride (usp)
34. Chebi:6961
35. Chembl1200534
36. Dtxsid7044267
37. Hy-b0378a
38. Moexipril Hydrochloride [mi]
39. Tox21_112590
40. S2079
41. Akos016340373
42. Tox21_112590_1
43. Bs-1007
44. Ccg-269939
45. Moexipril Hydrochloride [mart.]
46. Moexipril Hydrochloride [vandf]
47. Moexipril Hydrochloride [usp-rs]
48. Moexipril Hydrochloride [who-dd]
49. Ncgc00263546-01
50. 3-isoquinolinecarboxylic Acid, 1,2,3,4-tetrahydro-6,7-dimethoxy-2-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)-, Monohydrochloride, (3s-(2(r*(r*)),3r*))-
51. Bm164604
52. Smr002533645
53. Moexipril Hydrochloride [orange Book]
54. Sw219263-1
55. D00623
56. Moexipril Hydrochloride [usp Monograph]
57. Moexipril Hydrochloride, Powder, >=98% (hplc)
58. Uniretic Component Moexipril Hydrochloride
59. 586m525
60. A846428
61. Moexipril Hydrochloride Component Of Uniretic
62. Q27286898
63. Moexipril Hydrochloride, United States Pharmacopeia (usp) Reference Standard
64. (3s)-2-((2s)-2-(((1s)-1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)-1,2,3,4-tetrahydro-6,7-dimethoxy-3-isoquinolinecarboxylic Acid Hydrochloride
65. (s)-2-(((s)-1-ethoxy-1-oxo-4-phenylbutan-2-yl)-l-alanyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic Acid Hydrochloride
66. (s)-2-((s)-2-(((s)-1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino)propanoyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic Acid Hydrochloride
67. 2-[(2s)-2-[[(1s)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-3-isoquinolinecarboxylic Acid Hydrochloride
| Molecular Weight | 535.0 g/mol |
|---|---|
| Molecular Formula | C27H35ClN2O7 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 12 |
| Exact Mass | 534.2132792 g/mol |
| Monoisotopic Mass | 534.2132792 g/mol |
| Topological Polar Surface Area | 114 Ų |
| Heavy Atom Count | 37 |
| Formal Charge | 0 |
| Complexity | 742 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 3 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
| 1 of 6 | |
|---|---|
| Drug Name | Moexipril hydrochloride |
| Drug Label | Moexipril hydrochloride, the hydrochloride salt of moexipril, has the empirical formula C27H34N2O7.HCl and a molecular weight of 535.04. It is chemically described as [3S-[2[R*(R*)],3R*]]-2-[2-[[1-(ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-1... |
| Active Ingredient | Moexipril hydrochloride |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | 7.5mg; 15mg |
| Market Status | Prescription |
| Company | Teva; Apotex; Glenmark Generics; Paddock |
| 2 of 6 | |
|---|---|
| Drug Name | Uniretic |
| PubMed Health | Moexipril/Hydrochlorothiazide (By mouth) |
| Drug Classes | ACE Inhibitor/Thiazide Combination, Antihypertensive, Cardiovascular Agent |
| Active Ingredient | Hydrochlorothiazide; moexipril hydrochloride |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | 7.5mg; 25mg; 15mg; 12.5mg |
| Market Status | Prescription |
| Company | Ucb |
| 3 of 6 | |
|---|---|
| Drug Name | Univasc |
| PubMed Health | Moexipril (By mouth) |
| Drug Classes | Antihypertensive, Cardiovascular Agent, Renal Protective Agent |
| Drug Label | univasc (moexipril hydrochloride), the hydrochloride salt of moexipril, has the empirical formula C27H34N2O7HCl and a molecular weight of 535.04. It is chemically described as [3S-[2[R*(R*)],3R*]]-2-[2-[[1-(ethoxycarbonyl)-3-phenylpropyl]amino]-... |
| Active Ingredient | Moexipril hydrochloride |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | 7.5mg; 15mg |
| Market Status | Prescription |
| Company | Ucb |
| 4 of 6 | |
|---|---|
| Drug Name | Moexipril hydrochloride |
| Drug Label | Moexipril hydrochloride, the hydrochloride salt of moexipril, has the empirical formula C27H34N2O7.HCl and a molecular weight of 535.04. It is chemically described as [3S-[2[R*(R*)],3R*]]-2-[2-[[1-(ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-1... |
| Active Ingredient | Moexipril hydrochloride |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | 7.5mg; 15mg |
| Market Status | Prescription |
| Company | Teva; Apotex; Glenmark Generics; Paddock |
| 5 of 6 | |
|---|---|
| Drug Name | Uniretic |
| PubMed Health | Moexipril/Hydrochlorothiazide (By mouth) |
| Drug Classes | ACE Inhibitor/Thiazide Combination, Antihypertensive, Cardiovascular Agent |
| Active Ingredient | Hydrochlorothiazide; moexipril hydrochloride |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | 7.5mg; 25mg; 15mg; 12.5mg |
| Market Status | Prescription |
| Company | Ucb |
| 6 of 6 | |
|---|---|
| Drug Name | Univasc |
| PubMed Health | Moexipril (By mouth) |
| Drug Classes | Antihypertensive, Cardiovascular Agent, Renal Protective Agent |
| Drug Label | univasc (moexipril hydrochloride), the hydrochloride salt of moexipril, has the empirical formula C27H34N2O7HCl and a molecular weight of 535.04. It is chemically described as [3S-[2[R*(R*)],3R*]]-2-[2-[[1-(ethoxycarbonyl)-3-phenylpropyl]amino]-... |
| Active Ingredient | Moexipril hydrochloride |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | 7.5mg; 15mg |
| Market Status | Prescription |
| Company | Ucb |
Antihypertensive Agents
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)
Angiotensin-Converting Enzyme Inhibitors
A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility. (See all compounds classified as Angiotensin-Converting Enzyme Inhibitors.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seqens
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Boai NKY Pharmaceuticals Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ACG Worldwide
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Aeon Procare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Alcedo Pharmachem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Corel Pharma Chem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DFE Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Huzhou Sunflower Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ideal Cures Pvt Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ingredion Pharma Solutions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kima Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Lonza Capsugel
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nomisma Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Novo Excipients
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharmatrans-Sanaq
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Prachin Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qianhao Chemical (Hebei) Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qualicaps
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seppic
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Sigachi Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]The Dow Chemical Company
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ulanqab Kema New Material
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients by Applications
Fillers, Diluents & Binders
Coating Systems & Additives
Controlled & Modified Release
Direct Compression
Film Formers & Plasticizers
Granulation
Co-Processed Excipients
Solubilizers
Thickeners and Stabilizers
Lubricants & Glidants
Topical
Empty Capsules
Disintegrants & Superdisintegrants
Parenteral
Taste Masking
API Stability Enhancers
Coloring Agents
Chewable & Orodispersible Aids
Vegetarian Capsules
Emulsifying Agents
Rheology Modifiers
Digital Content
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?
Market Place
